Courtney Lawrence: It’s Critical That as Blood Donor Eligibility Criteria Evolves, We Ensure the U.S. Blood Supply for Patients Remains Safe!
Courtney Lawrence, Divisional Chief Medical Officer at the American Red Cross, shared on LinkedIn:
”It’s critical that as blood donor eligibility criteria evolves, we sensure the U.S. blood supply for patients remains safe!
With supporting data from the experiences of other countries and ongoing studies of specific donor subpopulations, the FDA reduced the deferral period for blood donors with specific higher risk behaviors from 12 months to 3 months in 2020.
(In 2023, another huge stride was made in moving to Individualized Donor Assessment, replacing blanket deferrals based on gender and sexual orientation with evidence-based individual assessments of risks).
‘Despite reducing donor deferral periods for many infectious risk behaviors, HIV and HBV prevalence were stable, while HCV prevalence declined over 8 years.
Either slight or significant declines occurred from the pre-3M to 3M period for all agents.
Thus, changes in policy did not adversely impact the current safety of the blood supply with respect to the major infectious disease agents.’
Congratulations to the science teams from American Red Cross’s Transfusion Safety and Surveillance, Vitalant, OneBlood, New York Blood Center and the FDA on their collaborative publication in AABB Transfusion!”

Stay updated on the emerging with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis
